BioSense Solus V2
The technology used in the BioSense Solus V2, to measure blood glucose, has failed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication. However, it was also assessed in another study but the results have not been published and cannot be verified.
|Medaval||None||While a clinical validation is claimed, it cannot be checked properly.|
|Institute of Health Economics (CA)||General use||No evidence provided|
Klonoff DC, Parkes JL, Kovatchev BP, Kerr D, Bevier WC, Brazg RL, Christiansen M, Bailey TS, Nichols JH, Kohn MA. Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors. Diabetes Care. 2018 Aug;41(8):1681-8. Epub: 2018 Jun 13. doi: 10.2337/dc17-1960. PMID: 29898901. Available from: www.diabetestechnology.org.
DTS:2016 - Fail General population